Lazard Asset Management »

Bridgebio Pharma shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 143k 74.26
2025-12-31 $4.2M 55k 76.49
2025-09-30 $42k 814 51.94
2024-09-30 $0 38 0.00
2024-06-30 $98k 3.9k 25.10
2023-03-31 $203k 12k 16.51
2022-12-31 $576k 76k 7.62
2022-09-30 $990k 100k 9.93
2022-06-30 $230k 25k 9.05
2022-03-31 $323k 32k 10.13
2021-12-31 $317k 19k 16.68
2021-09-30 $46k 982 46.84
2020-12-31 $478k 6.7k 71.07